help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, I. U.
Right arrow Articles by Turner, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, I. U.
Right arrow Articles by Turner, R. T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PARATHYROID HORMONE

Endocrinology, Vol 136, 5127-5134, Copyright © 1995 by Endocrine Society


ARTICLES

Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats

IU Schmidt, H Dobnig and RT Turner
Department of Orthopedics, Mayo Clinic, Rochester, Minnesota 55905, USA.

The effects of GH and PTH on cancellous histomorphometry were determined in the proximal tibial metaphysis of hypophysectomized (HYPOX) sexually mature female rats. HYPOX resulted in uterine atrophy and a loss in body weight. Longitudinal bone growth ceased and bone formation was greatly reduced. There were decreases in cancellous bone area, trabecular number, and trabecular thickness. Intermittent treatment with GH did not influence uterine weight in HYPOX rats. However, GH resulted in resumption of whole body weight gain, as well as maintenance of normal longitudinal bone growth. Additionally, GH partially maintained bone formation in HY POX rats and did not have a significant effect on steady state messenger RNA levels for osteocalcin. Intermittent treatment with PTH had no effect on whole body weight gain, uterine weight, or longitudinal bone growth. In contrast, PTH increased bone formation compared with the baseline, HYPOX, and GH-treated HYPOX rats, and dramatically increased osteocalcin messenger RNA levels compared with the latter two groups. The increased bone formation was primarily due to an increase in osteoblast number; the mineral apposition rate, an index of osteoblast activity, was increased compared with control and GH-treated rats but not compared with baseline values. Interestingly, neither treatment influenced indices of bone resorption.


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
D. Merciris, C. Marty, C. Collet, M.-C. de Vernejoul, and V. Geoffroy
Overexpression of the Transcriptional Factor Runx2 in Osteoblasts Abolishes the Anabolic Effect of Parathyroid Hormone in Vivo
Am. J. Pathol., May 1, 2007; 170(5): 1676 - 1685.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Q. Pirih, A. Tang, I. C. Ozkurt, J. M. Nervina, and S. Tetradis
Nuclear Orphan Receptor Nurr1 Directly Transactivates the Osteocalcin Gene in Osteoblasts
J. Biol. Chem., December 17, 2004; 279(51): 53167 - 53174.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
I. Ahmed, D. Gesty-Palmer, M. K. Drezner, and L. M. Luttrell
Transactivation of the Epidermal Growth Factor Receptor Mediates Parathyroid Hormone and Prostaglandin F2{alpha}-Stimulated Mitogen-Activated Protein Kinase Activation in Cultured Transgenic Murine Osteoblasts
Mol. Endocrinol., August 1, 2003; 17(8): 1607 - 1621.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
V. Krishnan, T. L. Moore, Y. L. Ma, L. M. Helvering, C. A. Frolik, K. M. Valasek, P. Ducy, and A. G. Geiser
Parathyroid Hormone Bone Anabolic Action Requires Cbfa1/Runx2-Dependent Signaling
Mol. Endocrinol., March 1, 2003; 17(3): 423 - 435.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
J. L. Vahle, M. Sato, G. G. Long, J. K. Young, P. C. Francis, J. A. Engelhardt, M. S. Westmore, Y. L. Ma, and J. B. Nold
Skeletal Changes in Rats Given Daily Subcutaneous Injections of Recombinant Human Parathyroid Hormone (1-34) for 2 Years and Relevance to Human Safety
Toxicol Pathol, April 1, 2002; 30(3): 312 - 321.
[Abstract] [PDF]


Home page
EndocrinologyHome page
N. Miyakoshi, Y. Kasukawa, T. A. Linkhart, D. J. Baylink, and S. Mohan
Evidence That Anabolic Effects of PTH on Bone Require IGF-I in Growing Mice
Endocrinology, October 1, 2001; 142(10): 4349 - 4356.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. L. Ma, R. L. Cain, D. L. Halladay, X. Yang, Q. Zeng, R. R. Miles, S. Chandrasekhar, T. J. Martin, and J. E. Onyia
Catabolic Effects of Continuous Human PTH (1-38) in Vivo Is Associated with Sustained Stimulation of RANKL and Inhibition of Osteoprotegerin and Gene-Associated Bone Formation
Endocrinology, September 1, 2001; 142(9): 4047 - 4054.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
W.G. Young, H. Li, Y. Xiao, M.J. Waters, and P.M. Bartold
Growth-hormone-stimulated Dentinogenesis in Lewis Dwarf Rat Molars
Journal of Dental Research, August 1, 2001; 80(8): 1742 - 1747.
[Abstract] [PDF]


Home page
EndocrinologyHome page
R. R. Miles, J. P. Sluka, D. L. Halladay, R. F. Santerre, L. V. Hale, L. Bloem, K. Thirunavukkarasu, R. J. S. Galvin, J. M. Hock, and J. E. Onyia
ADAMTS-1: A Cellular Disintegrin and Metalloprotease with Thrombospondin Motifs Is a Target for Parathyroid Hormone in Bone
Endocrinology, December 1, 2000; 141(12): 4533 - 4542.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
S. Soma, S. Matsumoto, Y. Higuchi, T. Takano-Yamamoto, K. Yamashita, K. Kurisu, and M. Iwamoto
Local and Chronic Application of PTH Accelerates Tooth Movement in Rats
Journal of Dental Research, September 1, 2000; 79(9): 1717 - 1724.
[Abstract] [PDF]


Home page
EndocrinologyHome page
M. Amling, M. Priemel, T. Holzmann, K. Chapin, J. M. Rueger, R. Baron, and M. B. Demay
Rescue of the Skeletal Phenotype of Vitamin D Receptor-Ablated Mice in the Setting of Normal Mineral Ion Homeostasis: Formal Histomorphometric and Biomechanical Analyses
Endocrinology, November 1, 1999; 140(11): 4982 - 4987.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. K. Yeh, J. F. Evans, M.-M. Chen, and J. F. Aloia
Effect of hypophysectomy on the proliferation and differentiation of rat bone marrow stromal cells
Am J Physiol Endocrinol Metab, January 1, 1999; 276(1): E34 - E42.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Ohlsson, B.-A. Bengtsson, O. G. P. Isaksson, T. T. Andreassen, and M. C. Slootweg
Growth Hormone and Bone
Endocr. Rev., February 1, 1998; 19(1): 55 - 79.
[Abstract] [Full Text]


Home page
J. Appl. Physiol.Home page
K. C. Westerlind, J. D. Fluckey, S. E. Gordon, W. J. Kraemer, P. A. Farrell, and R. T. Turner
Effect of resistance exercise training on cortical and cancellous bone in mature male rats
J Appl Physiol, February 1, 1998; 84(2): 459 - 464.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Dobnig and R. T. Turner
The Effects of Programmed Administration of Human Parathyroid Hormone Fragment (1-34) on Bone Histomorphometry and Serum Chemistry in Rats
Endocrinology, November 1, 1997; 138(11): 4607 - 4612.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. K. Yeh, M.-M. Chen, and J. F. Aloia
Effects of estrogen and growth hormone on skeleton in the ovariectomized rat with hypophysectomy
Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E734 - E742.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society